Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation. | Sci Rep | 2022 | 35715447 | PubTator, text mining | PubMed |
| Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives. | Vasc Health Risk Manag | 2022 | 35707632 | PubTator, text mining | PubMed |
| Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review. | Blood Coagul Fibrinolysis | 2022 | 35703225 | PubTator, text mining | PubMed |
| Building the blueprint: Formulating a community-generated national plan for future research in inherited bleeding disorders. | Haemophilia | 2022 | 35700441 | PubTator, text mining | PubMed |
| Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis. | Sci Rep | 2022 | 35697739 | PubTator, text mining | PubMed |
| Case Report: Presence of Anti-MAG in the CSF Can Be Associated With a Neurodegenerative Process With Frontal Involvement. | Front Neurol | 2022 | 35693016 | PubTator, text mining | PubMed |
| Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients. | Front Med (Lausanne) | 2022 | 35685422 | PubTator, text mining | PubMed |
| An Insight into Recent Advances on Platelet Function in Health and Disease. | Int J Mol Sci | 2022 | 35682700 | PubTator, text mining | PubMed |
| Treatment Adherence and Health-Related Quality of Life in Patients with Hemophilia in Hong Kong. | Int J Environ Res Public Health | 2022 | 35682087 | PubTator, text mining | PubMed |
| A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection. | Int J Cardiol Heart Vasc | 2022 | 35677840 | PubTator, text mining | PubMed |
| Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo. | Front Cardiovasc Med | 2022 | 35669477 | PubTator, text mining | PubMed |
| Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort. | Commun Biol | 2022 | 35668171 | PubTator, text mining | PubMed |
| Management of acute renal replacement therapy in critically ill cirrhotic patients. | Clin Kidney J | 2022 | 35664279 | PubTator, text mining | PubMed |
| Noninvasive proteomic biomarkers for alcohol-related liver disease. | Nat Med | 2022 | 35654907 | PubTator, text mining | PubMed |
| Investigation on abnormal gene loci of a Chinese pedigree with hereditary combined deficiency of blood coagulation factor XI, XII, and protein S. | Blood Cells Mol Dis | 2022 | 35653893 | PubTator, text mining | PubMed |
| Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability. | Arterioscler Thromb Vasc Biol | 2022 | 35652333 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Anticoagulation in Organ Fibrosis. | Front Med (Lausanne) | 2022 | 35652066 | PubTator, text mining | PubMed |
| Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections. | JHEP Rep | 2022 | 35647501 | PubTator, text mining | PubMed |
| Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation. | Res Pract Thromb Haemost | 2022 | 35647477 | PubTator, text mining | PubMed |
| Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence. | Front Cardiovasc Med | 2022 | 35647061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=37